Tagged Content
Everything on the platform tagged with ehr-integration.
Carta Healthcare is a San Francisco health-tech company that pairs AI with expert nurse abstractors to pull clean, registry-ready data out of messy electronic medical records. Its Atlas and Lighthouse products cut abstraction costs by more than half while hitting 98-99% inter-rater reliability, freeing clinicians and hospitals from the slow, expensive grind of manual chart review.
House Rx is a San Francisco-based healthcare technology company that partners with specialty clinics to enable medically integrated dispensing (MID) - a model where physicians, pharmacists, nurses, and care coordinators work together as one unified team. Founded in 2021 by Flatiron Health veterans Ogi Kavazovic and Tesh Khullar, the company builds AI-enabled pharmacy management software that keeps specialty medications dispensed at the point of care, cutting average time-to-therapy from 15.5 days to 3.5 days and achieving 95% medication adherence. With $100M raised across Seed, Series A, and Series B rounds, House Rx serves 80 clinic sites, 1,000+ providers, and nearly 61,000 patients, processing approximately $1.5 billion in specialty prescriptions annually.
Adnan Iqbal is the Co-Founder and CEO of Luma Health, a San Mateo-based healthcare technology company that has built an AI-native Patient Success Platform used by 750+ healthcare organizations, 100 million patients, and 500,000+ providers. A second-generation Pakistani-American and serial entrepreneur, Iqbal studied environmental biology at UC Berkeley, earned an MPhil in BioScience from Cambridge University, and an MS/MBA from Stanford GSB. Before Luma, he spent five years in management at Genentech and co-founded AutoTB, a tuberculosis diagnostic startup that won both Cambridge and UC Berkeley entrepreneurship competitions. Luma Health has raised $160 million in funding and enabled $3.2 billion in healthcare revenue.
Derek Chung is a software engineer at Abridge, the AI-powered clinical documentation company backed by Andreessen Horowitz with over $907M in total funding. A Stanford-trained computer scientist and accomplished concert pianist, he co-founded 88Keys to Cure, a nonprofit merging classical music with charitable causes, and has performed at Carnegie Hall's Weill Recital Hall, Chicago Symphony Orchestra Hall, and Ravinia. His career sits at a rare intersection: elite competitive piano, rigorous CS training, and building technology that reduces clinician burnout at scale.
Erez Druk is the co-founder and CEO of Freed, an AI medical scribe that automates clinical documentation for physicians. A Technion-educated engineer who cut his teeth at Facebook, Druk built Freed after watching his wife - a family medicine physician - spend her evenings buried in patient notes. Since launching in 2023, Freed has grown to over 25,000 paying clinicians across 96 specialties, saved more than 2.7 million hours of documentation time, and raised a $30 million Series A led by Sequoia Capital. Before Freed, Druk co-founded UrbanLeap, a government procurement platform that served 35 municipalities before closing in 2022.
Hamed Ahmadi is the Co-Founder and CEO of Medsien, a leading AI-powered remote care management company headquartered in San Francisco. A PhD mathematician turned Silicon Valley engineer turned healthcare entrepreneur, Ahmadi co-founded Medsien in 2018 alongside Sina Torabi with a mission to extend quality care beyond clinic walls to the 150 million Americans living with chronic conditions. Under his leadership, Medsien has grown to 110 employees, $12.7M in annual revenue, and raised $5.3M in funding, powering remote care programs for hundreds of healthcare organizations across the US.
Ian Christopher is the Co-Founder and Chief Engineer of Qventus, the AI-powered hospital operations platform backed by KKR and Bessemer Venture Partners. A Stanford-trained computational engineer, he co-built Qventus from a 2012 YC startup into a $400M+ company that automates how hospitals manage patient flow, surgical scheduling, and care coordination - reducing staff burnout and cutting length of stay for major health systems across the US.
Pranay Kapadia is the Co-Founder and CEO of Notable, an AI-powered automation platform for healthcare that eliminates administrative burden for clinicians and health systems. Founded in 2017 after dinner-table conversations with six physician family members - including his psychiatrist wife who called herself 'the highest paid data collector in the world' - Notable has grown to serve 32 million patients across 12,000 sites of care, raised $119.2M in funding including a $100M Series B in 2021, and now automates over one million repetitive healthcare workflows daily. Before Notable, Kapadia helped build Mint.com at Intuit and was on the founding team at Blend, the mortgage fintech unicorn.
Rad AI builds generative-AI software that drafts the most tedious parts of a radiology report - the impressions, the follow-ups, the boilerplate - so radiologists can spend more time on the images and less on the keyboard. Founded in 2018 by a radiologist (Jeff Chang) and a serial founder (Doktor Gurson), the company now works with roughly nine of the ten largest radiology groups in the U.S. and touches close to half of the country's medical imaging.
Shiv Rao is the CEO and co-founder of Abridge, the AI platform transforming clinical conversations into structured medical documentation. A practicing cardiologist at UPMC and history-major-turned-physician, Rao founded Abridge in 2018 out of personal frustration with nightly dictation sessions. The company, now valued at $5.3 billion after raising $300M in Series E in 2025, deploys across 150+ U.S. health systems including Mayo Clinic, Duke Health, and Johns Hopkins, supports 28 languages and 55 medical specialties, and is used by over 50,000 clinicians. Rao is equal parts cardiologist, technologist, and artist — a former DJ, skateboarder, and avant-garde music producer whose unconventional path runs straight through the operating room.

Rich Waller is President and CEO of WellStack, a Madison, Wisconsin-based healthcare data platform that helps provider and payer organizations build a unified data ecosystem for AI, analytics, and population health management. A 20-year veteran of healthcare technology, Waller co-founded VisiQuate - a healthcare revenue cycle analytics company - before joining WellStack to lead its expansion into enterprise healthcare data infrastructure. He is known for his client-centered philosophy and belief that growth strategy is a team sport.
Nishith Khandwala (Nish) is the co-founder and CEO of Bunkerhill Health, a San Francisco-based AI company building the operating system for clinical action inside health systems. A Stanford computer scientist who started in AI labs with no healthcare background, he pivoted after physicians walked in with real clinical problems - and after his own father's heart attack forced him to ask why his coronary calcium AI wasn't reaching patients. Bunkerhill's Carebricks platform now powers 7+ clinical domains at major health systems including UTMB, HCA Florida, MedStar, and WVU Medicine. The company has raised $30.4M from Sequoia, Optum Ventures, and Y Combinator, earned multiple FDA clearances, and landed Nishith on Forbes 30 Under 30 and the inaugural Mayfield Divot AI List.
Mark Lee, MD, PhD is the CEO and Co-Founder of N-Power Medicine, a Redwood City-based company reinventing how oncology clinical trials reach patients. A medical oncologist and scientist trained at Stanford and Harvard, Lee has spent his career at the frontier of personalized medicine - from developing Oncotype DX diagnostics at Genomic Health, to helping build early cancer detection at GRAIL, to leading personalized healthcare at Genentech/Roche. In 2021, he co-founded N-Power Medicine to embed research infrastructure directly into community oncology clinics, combining AI, embedded staff, and real-time registries to dramatically expand clinical trial access. After raising a $72M Series B led by Merck's Global Health Innovation Fund, N-Power acquired Syapse in late 2024 to build the largest community-based prospective clinical research network in oncology.